AXLA — Axcella Health Share News
0.000.00%
Last trade - 00:00Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment
U.S. STOCKS ON THE MOVE-Zoom, Coinbase, Lowe's
Brief: Axcella Therapeutics posts Q2 basic EPS USD -0.05
Brief: Axcella Health Says On June 29, Was Notified By Nasdaq Regarding Co's Non-Compliance With $1.00 Bid Price Rule As Of June 28
Brief: Axcella Reports First Quarter Financial Results
Axcella Health Inc expected to post a loss of 16 cents a share - Earnings Preview
Media: U.S. biotech Axcella seeks funds for long COVID drug shown to ease fatigue - Bloomberg News
Brief: Axcella Health Inc Says On April 3, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Axcella Health Inc reports results for the quarter ended in December - Earnings Summary
Brief: Axcella Reports Fourth Quarter And Full Year 2022 Financial Results
Axcella Health Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-LabCorp, dental stocks, Community Health
U.S. STOCKS ON THE MOVE-Truist Financial, Microsoft, NRG Energy
U.S. STOCKS ON THE MOVE-Datadog, Crocs, Applied Therapeutics
U.S. STOCKS ON THE MOVE-Ford, Emergent Bio, Shopify
Axcella surges on FDA's nod to begin human study for long COVID fatigue treatment